These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. Inhibition of antigen-induced lung anaphylaxis in the guinea-pig by BN 52021 a new specific paf-acether receptor antagonist isolated from Ginkgo biloba. Touvay C; Etienne A; Braquet P Agents Actions; 1986 Jan; 17(3-4):371-2. PubMed ID: 3754380 [TBL] [Abstract][Full Text] [Related]
3. Protection by two ginkgolides, BN-52020 and BN-52021, against guinea-pig lung anaphylaxis. Berti F; Omini C; Rossoni G; Braquet P Pharmacol Res Commun; 1986 Sep; 18(9):775-93. PubMed ID: 3099317 [TBL] [Abstract][Full Text] [Related]
4. The role of PAF-acether in anaphylaxis demonstrated with the use of the antagonist BN 52021. Braquet P; Guinot P; Touvay C Agents Actions Suppl; 1987; 21():97-117. PubMed ID: 3314418 [No Abstract] [Full Text] [Related]
5. Interference of BN 52021 (ginkgolide B) with the bronchopulmonary effects of PAF-acether in the guinea-pig. Desquand S; Touvay C; Randon J; Lagente V; Vilain B; Maridonneau-Parini I; Etienne A; Lefort J; Braquet P; Vargaftig BB Eur J Pharmacol; 1986 Aug; 127(1-2):83-95. PubMed ID: 3019727 [TBL] [Abstract][Full Text] [Related]
6. Proof of the involvement of platelet activating factor (paf-acether) in pulmonary complex immune systems using a specific paf-acether receptor antagonist: BN 52021. Touvay C; Vilain B; Taylor JE; Etienne A; Braquet P Prog Lipid Res; 1986; 25(1-4):277-88. PubMed ID: 2827186 [No Abstract] [Full Text] [Related]
7. A study with BN 52021 demonstrates the involvement of PAF-acether in IgE-dependent anaphylactic bronchoconstriction. Cirino M; Lagente V; Lefort J; Vargaftig BB Prostaglandins; 1986 Jul; 32(1):121-6. PubMed ID: 3763941 [TBL] [Abstract][Full Text] [Related]
8. Proofs of involvement of PAF-acether in various immune disorders using BN 52021 (ginkgolide B): a powerful PAF-acether antagonist isolated from Ginkgo biloba L. Braquet P Adv Prostaglandin Thromboxane Leukot Res; 1986; 16():179-98. PubMed ID: 2949548 [No Abstract] [Full Text] [Related]
9. Interference of the PAF-acether antagonist BN 52021 with passive anaphylaxis in the guinea-pig. Lagente V; Touvay C; Randon J; Desquand S; Cirino M; Vilain B; Lefort J; Braquet P; Vargaftig BB Prostaglandins; 1987 Feb; 33(2):265-74. PubMed ID: 2438723 [TBL] [Abstract][Full Text] [Related]
10. Pharmacological control of the in vivo passive anaphylactic shock by the PAF-acether antagonist compound BN 52021. Vilain B; Lagente V; Touvay C; Desquand S; Randon J; Lefort J; Braquet P; Vargaftig BB Pharmacol Res Commun; 1986 Aug; 18 Suppl():119-26. PubMed ID: 3774840 [TBL] [Abstract][Full Text] [Related]
11. Thrombus induction by endogenic paf-acether and its inhibition by Ginkgo Biloba extracts in the guinea pig. Bourgain RH; Maes L; Andries R; Braquet P Prostaglandins; 1986 Jul; 32(1):142-4. PubMed ID: 3763943 [TBL] [Abstract][Full Text] [Related]
12. Effect of BN 52021, a specific PAF-acether antagonist, on cardiac anaphylaxis in Langendorff hearts isolated from passively sensitized guinea-pigs. Koltai M; Lepran I; Szekeres L; Viossat I; Chabrier E; Braquet P Eur J Pharmacol; 1986 Oct; 130(1-2):133-6. PubMed ID: 3780855 [TBL] [Abstract][Full Text] [Related]
13. Effect of ginkgolide PAF-acether antagonists on arterial thrombosis. Bourgain RH; Andries R; Braquet P Adv Prostaglandin Thromboxane Leukot Res; 1987; 17B():815-7. PubMed ID: 2960196 [TBL] [Abstract][Full Text] [Related]
14. Inhibition of the vascular actions of IgG aggregates by BN 52021, a highly specific antagonist of paf-acether. Sánchez-Crespo M; Fernández-Gallardo S; Nieto ML; Baranès J; Braquet P Immunopharmacology; 1985 Oct; 10(2):69-75. PubMed ID: 3840779 [TBL] [Abstract][Full Text] [Related]
15. Changes in cytosolic free calcium induced by platelet-activating factor in rabbit platelets: specific inhibition by BN 52021 and structurally related compounds. Baroggi N; Etienne A; Braquet P Agents Actions Suppl; 1986; 20():87-97. PubMed ID: 3028108 [TBL] [Abstract][Full Text] [Related]
16. The effects of PAF-acether on the cardiovascular system and their inhibition by a new highly specific PAF-acether receptor antagonist BN 52021. Baranes J; Hellegouarch A; Le Hegarat M; Viossat I; Auguet M; Chabrier PE; Braquet P Pharmacol Res Commun; 1986 Aug; 18(8):717-37. PubMed ID: 3763677 [TBL] [Abstract][Full Text] [Related]
17. Interference of BN 52021, a PAF-acether antagonist, with endotoxin-induced hypotension in the guinea-pig. Adnot S; Lefort J; Lagente V; Braquet P; Vargaftig BB Pharmacol Res Commun; 1986 Aug; 18 Suppl():197-200. PubMed ID: 3774845 [No Abstract] [Full Text] [Related]
18. Effect of BN 52021, a specific antagonist of platelet activating factor (PAF-acether), on calcium movements and phosphatidic acid production induced by PAF-acether in human platelets. Simon MF; Chap H; Braquet P; Douste-Blazy L Thromb Res; 1987 Feb; 45(4):299-309. PubMed ID: 3576518 [TBL] [Abstract][Full Text] [Related]
19. Effects of platelet-activating factor on electrophysiology of isolated retinas and their inhibition by BN 52021, a specific PAF-acether receptor antagonist. Doly M; Bonhomme B; Braquet P; Chabrier PE; Meyniel G Immunopharmacology; 1987 Jun; 13(3):189-94. PubMed ID: 3038784 [TBL] [Abstract][Full Text] [Related]
20. Interference of the PAF-acether antagonist BN 52021 with endotoxin-induced hypotension in the guinea-pig. Adnot S; Lefort J; Braquet P; Vargaftig BB Prostaglandins; 1986 Dec; 32(6):791-802. PubMed ID: 3562865 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]